135 related articles for article (PubMed ID: 24649554)
41. Effectiveness of treatments for metastatic uveal melanoma.
Augsburger JJ; Corrêa ZM; Shaikh AH
Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
[TBL] [Abstract][Full Text] [Related]
42. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.
Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA
Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116
[TBL] [Abstract][Full Text] [Related]
43. Mouse pigmentation mutants help identify a uveal melanoma oncogene.
Hayward NK
Pigment Cell Melanoma Res; 2009 Feb; 22(1):2-3. PubMed ID: 19140886
[No Abstract] [Full Text] [Related]
44. Metastatic disease from uveal melanomas. A review of current concepts with comments concerning future research and prevention.
Zimmerman LE
Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):34-54. PubMed ID: 7022781
[No Abstract] [Full Text] [Related]
45. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
Filer RS; Song JC; Char DH; Kaleta-Michaels S
Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
[TBL] [Abstract][Full Text] [Related]
46. Uveal melanoma: genetic aspects.
Singh AD; Damato B; Howard P; Harbour JW
Ophthalmol Clin North Am; 2005 Mar; 18(1):85-97, viii. PubMed ID: 15763194
[TBL] [Abstract][Full Text] [Related]
47. [Risk factors of extraocular spread after local treatment of uveal melanoma].
Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV
Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267
[TBL] [Abstract][Full Text] [Related]
48. The T1799A point mutation is present in posterior uveal melanoma.
Janssen CS; Sibbett R; Henriquez FL; McKay IC; Kemp EG; Roberts F
Br J Cancer; 2008 Nov; 99(10):1673-7. PubMed ID: 18985043
[TBL] [Abstract][Full Text] [Related]
49. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
50. Cytogenetics and prognosis for uveal melanoma in Korean patients.
Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
[TBL] [Abstract][Full Text] [Related]
51. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
[TBL] [Abstract][Full Text] [Related]
52. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
53. Uveal melanoma: update and future directions.
Rousseau AP
Can J Ophthalmol; 2004 Jun; 39(4):335-42. PubMed ID: 15327097
[TBL] [Abstract][Full Text] [Related]
54. Blood biomarkers of uveal melanoma metastasis.
Triozzi PL; Singh AD
Br J Ophthalmol; 2011 Jan; 95(1):3-4. PubMed ID: 21163819
[No Abstract] [Full Text] [Related]
55. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.
Laurent C; Valet F; Planque N; Silveri L; Maacha S; Anezo O; Hupe P; Plancher C; Reyes C; Albaud B; Rapinat A; Gentien D; Couturier J; Sastre-Garau X; Desjardins L; Thiery JP; Roman-Roman S; Asselain B; Barillot E; Piperno-Neumann S; Saule S
Cancer Res; 2011 Feb; 71(3):666-74. PubMed ID: 21135111
[TBL] [Abstract][Full Text] [Related]
56. [Round table discussion: Treatment of uveal melanoma].
Blodi FC; Foerster M; Hallermann D; Lund OE; Meyer-Schwickerath G; Straatsma B; Zimmerman LE
Fortschr Ophthalmol; 1983; 80(6):443-7. PubMed ID: 6662447
[No Abstract] [Full Text] [Related]
57. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
58. Metastasis from uveal melanoma associated with congenital ocular melanocytosis: a matched study.
Mashayekhi A; Kaliki S; Walker B; Park C; Sinha N; Kremer FZ; Shields CL; Shields JA
Ophthalmology; 2013 Jul; 120(7):1465-8. PubMed ID: 23522968
[TBL] [Abstract][Full Text] [Related]
59. Molecular characteristics of liver metastases from uveal melanoma.
Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
[TBL] [Abstract][Full Text] [Related]
60. Novel treatment paradigms for metastatic uveal melanoma.
Patel SP; Katz SC
Cancer Gene Ther; 2022 Dec; 29(12):1807-1808. PubMed ID: 36456705
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
